Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001946439-25-000019
Filing Date
2025-12-19
Accepted
2025-12-19 16:47:05
Documents
1
Period of Report
2025-12-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1766180822.html 4  
1 FORM 4 wk-form4_1766180822.xml 4 3343
  Complete submission text file 0001946439-25-000019.txt   4974
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ANI PHARMACEUTICALS, INC. 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address
Davis Krista (Reporting) CIK: 0001946439 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 251588216